[1] |
XIE Rui, GENG Zihan, BAO Lei, ZHAO Ronghua, LI Shuran, SUN Qiyue, WANG Xinwei, ZHANG Jingsheng, CUI Xiaolan, GUO Shanshan, SUN Jing.
Research Progress in Pharmacological Actions, Mechanisms, Structural Modifications and Targeted Formulations of Ribavirin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 950-955.
|
[2] |
HU Haipeng, YAO Weijie, FENG Xin.
Effects of Yangxue Antai Prescription on Placental Ferroptosis in Recurrent Spontaneous Abortion Mice
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 621-626.
|
[3] |
LIU Lianlian, YU Huiyong, WANG Mingzhe, GUO Shanshan, LI Lei, GAO Yue, WEI Shixiang, KE Yinze, WANG Chengxiang.
TCM Medications for Pulmonary Nodules Based on Traditional Chinese Medicine Inheritance Assistance System
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 513-516.
|
[4] |
SU Hai, ZAN Mengqing, NIU Jianzhao, MA Lingyun, LIU Qian.
Effect of ethanol on release behavior of glipizide controlled release tablets by HPLC
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 638-643.
|
[5] |
RU Chen, HOU Xiujuan, QIAN Tangliang, DU Mengmeng, LI Yuan, LIU Xiaoping, ZHU Yuelan.
Compatibility and mechanism of a Chinese medicine compound in treating Sjogren's syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 397-403.
|
[6] |
LIU Wenjie, GAO Yuanyuan, BAI Xue.
Advancements in Treating Ischemic Stroke with Chinese Medicine Compounds Formulae
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1382-1387.
|
[7] |
LIU Zhejun, TANG Tian, TAN Tianyang, BAI Xue.
Research Progress on Traditional Chinese Medicine Compound Formulae against Hemorrhagic Stroke
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1405-1410.
|
[8] |
ZHANG Jianwei, LIU Li, XU Guanglin, SHI Xiaoli.
Lujiao Formula Inhibiting Cardiac Hypertrophy Induced by Ang Ⅱ through Regulating the NF-κB Pathways
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1250-1255.
|
[9] |
WANG Xiang, SUN Shuai, WANG Xinguo, NIU Liying.
Quantitative transfer relationships of Rubia yunnanensis Diels formula granules based on standard decoctions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 891-898.
|
[10] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|
[11] |
FU Mengjun, YAO Huihui, ZHU Kexu, WANG Xinyuan, YAO Shangchen.
Evaluation of dissolution curves of indapamide tablets between generics and reference formulation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 763-768.
|
[12] |
HUANG Yinyin, ZHANG Liwen, LIU Jing, CHEN Jing, ZHOU Yuanhua, XU Mingzhe, YAO Shangchen, WANG Chen, ZHANG Xianhua.
Preparation, characterization and stability of three forms of prulifloxacin
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 374-378.
|
[13] |
LUO Yaqin, ZHANG Lanhong, HUANG Wei.
Comparative study on therapeutic effects of Qihuang Yiqi Shexue Formula prepared by different extraction processes on ITP model mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1191-1195.
|
[14] |
LUO Yaqin, CAI Qiang, HUANG Wei.
Therapeutic effect and anti-inflammatory mechanism of Qihuang Yiqi Shexue Formula in ITP model mice
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1073-1077.
|
[15] |
WANG Luyao, DENG Zhe, XIAO Suping, ZHANG Quan, OUYANG Luodan, CHEN Meng, ZHOU Haiyan, WANG Jiyong, DU Jie.
Modern Clinical Applications and Analysis of Linggui Zhugan Decoction
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1066-1069.
|